With $2 billion from the Biden administration, biomanufacturing in the U.S. is poised for significant growth. The economy may be, too.
Bio + Life Sciences
While working to understand not only his own rare disease but also how the broader healthcare industry develops treatments for rare diseases as a whole, Onno Faber uncovered the building blocks of his new company.
For the first time, the White House tells scientific publishers to take down the paywalls around federally funded research.
Global warming has, in certain instances, amped up some of the world’s most deadly diseases.
In his latest book, clinical geneticist and biotech entrepreneur Dr. Phil Reilly chronicles centuries of medical progress that have contributed to recent breakthroughs in rare disease medicines, diagnostics, and clinical care. He says we're just...
We know more than ever about the abundance of life in the soil. Now we have to step up to save it.